Ⓒ 2024 Beye.com. All rights reserved.
This content is intended for health care professionals and providers only. The information contained on Beye.com, including text, graphics, images, and interactive activities, is for informational purposes only, and is not intended to be a substitute for professional medical advice. Beye LLC, via its Editors and Publisher, accepts no responsibility for any injury or damage to persons or property occasioned through the implementation of any ideas or use of any product described herein. Although great care is taken to ensure that all information is accurate, it is recommended that readers seek independent verification of advice on drugs and other product usage, surgical techniques and clinical processes prior to their use. References made in article may indicate usage of medical equipment or drugs at dosages, for periods of time, and in combination not included in the current prescribing information. Inclusion of advertising materials on the website thereof, does not constitute and representation or guarantee by Beye LLC of the quality of such products, or of the claims made.
reset all
At-a-Glance
Description
CentraSight is a new treatment program using a tiny telescope that is implanted inside the eye to improve vision and quality of life for patients with the most advanced form of macular degeneration: end-stage AMD.
The Argus II Retinal Prosthesis System ("Argus II") is the world's first approved device intended to restore some functional vision for people suffering from blindness. It is intended to provide electrical stimulation of the retina to elicit visual perception in blind individuals with severe to profound retinitis pigmentosa. The implant is often referred to as the bionic eye.